{"id":95151,"date":"2025-12-02T08:30:12","date_gmt":"2025-12-02T08:30:12","guid":{"rendered":"https:\/\/www.europesays.com\/se\/95151\/"},"modified":"2025-12-02T08:30:12","modified_gmt":"2025-12-02T08:30:12","slug":"vanliga-halsotillstand-kan-paverka-blodtest-for-alzheimers-visar-studie","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/95151\/","title":{"rendered":"Vanliga h\u00e4lsotillst\u00e5nd kan p\u00e5verka blodtest f\u00f6r Alzheimers visar studie"},"content":{"rendered":"<p>Bild:<\/p>\n<p> <img decoding=\"async\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/12\/Makrina_Daniilidou_Profilephoto_custom20251201075354.webp.webp\" alt=\"bild p\u00e5 Makrina Daniilidou, forskare vid avdelningen f\u00f6r klinisk geriatrik, NVS.\"\/><\/p>\n<p>Rubrik:<\/p>\n<p> Makrina Daniilidou, forskare vid avdelningen f\u00f6r klinisk geriatrik, NVS.<br \/>\nFoto: Privat<\/p>\n<p>\u2013 Vi s\u00e5g att flera h\u00e4lsorelaterade faktorer var kopplade till f\u00f6r\u00e4ndringar i biomark\u00f6rniv\u00e5er, s\u00e4ger <a href=\"https:\/\/ki.se\/personer\/makrina-daniilidou\" data-entity-type=\"external\" rel=\"nofollow noopener\" target=\"_blank\">Makrina Daniilidou<\/a>, forskare vid <a href=\"https:\/\/ki.se\/nvs\" data-entity-type=\"external\" rel=\"nofollow noopener\" target=\"_blank\">institutionen f\u00f6r neurobiologi, v\u00e5rdvetenskap och samh\u00e4lle<\/a>, Karolinska Institutet. Till exempel p\u00e5verkade diabetes och dyslipidemi amyloidmark\u00f6rer \u00e4ven n\u00e4r vi tog h\u00e4nsyn till Alzheimers patologi, vilket tyder p\u00e5 effekter utanf\u00f6r hj\u00e4rnan.<\/p>\n<p>En viktig observation: <strong>p-tau217<\/strong>, som anses vara den mest lovande biomark\u00f6ren, f\u00f6rblev mycket robust trots \u00f6vriga sjukdomars p\u00e5verkan. D\u00e4remot skedde vissa f\u00f6r\u00e4ndringar i kliniska gr\u00e4nsv\u00e4rden n\u00e4r samsjuklighet beaktades. I kontrast var <strong>A\u03b242\/40-kvoten<\/strong> mer k\u00e4nslig f\u00f6r systemiska h\u00e4lsotillst\u00e5nd.<\/p>\n<p>Varf\u00f6r \u00e4r detta viktigt? Enligt forskarna fungerar de flesta biomark\u00f6rer fortfarande bra, men tolkningen kan f\u00f6rb\u00e4ttras genom att ta h\u00e4nsyn till patientens totala h\u00e4lsoprofil.\u00a0<\/p>\n<p>\u2013 Dessa tester \u00e4r ett stort steg fram\u00e5t, s\u00e4ger Makrina Daniilidou. V\u00e5ra resultat visar att de \u00e4r tillf\u00f6rlitliga, men ocks\u00e5 att det finns behov av ett mer personanpassat arbetss\u00e4tt.<\/p>\n<p>N\u00e4sta steg \u00e4r att bekr\u00e4fta resultaten i st\u00f6rre och mer varierade populationer, inklusive kognitivt friska personer med \u00f6kad risk f\u00f6r demens. M\u00e5let: att integrera justerade biomark\u00f6rmodeller i kliniska rutiner f\u00f6r en mer precis diagnostik av Alzheimers sjukdom. Seniora medf\u00f6rfattare bakom studien \u00e4r professor Miia Kivipelto och docent Anna Matton,\u00a0b\u00e5da verksamma vid Karolinska Institutet.<\/p>\n<p>Huvudfinansi\u00e4rer av studien\u00a0<\/p>\n<ol>\n<li>Innovative Health Initiative Joint Undertaking (JU) -PROMINENT under grant agreement No. 101112145 with support from BioArctic<\/li>\n<li>Innovative Health Initiative Joint Undertaking (JU) AD-RIDDLE, under grant agreement No. 101132933<\/li>\n<li>Alzheimer\u2019s Drug Discovery Foundation (USA)<\/li>\n<\/ol>\n<p>Publikation<\/p>\n<p><a href=\"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/alz.70931\" data-entity-type=\"external\" rel=\"nofollow noopener\" target=\"_blank\">Enhancing diagnostic precision in Alzheimer&#8217;s disease: Impact of comorbidities on blood biomarkers for clinical integration.<\/a> Daniilidou M, \u00d6hlund-Wistbacka U, Hagman G, et al. Alzheimer&#8217;s Dement. 2025; 21:e7093. doi.org\/10.1002\/alz.70931<\/p>\n","protected":false},"excerpt":{"rendered":"Bild: Rubrik: Makrina Daniilidou, forskare vid avdelningen f\u00f6r klinisk geriatrik, NVS. Foto: Privat \u2013 Vi s\u00e5g att flera&hellip;\n","protected":false},"author":2,"featured_media":95152,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69],"tags":[113,112,34,31,33,32,30],"class_list":{"0":"post-95151","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-halsa","8":"tag-halsa","9":"tag-health","10":"tag-se","11":"tag-svenska","12":"tag-sverige","13":"tag-sweden","14":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115649041209817492","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/95151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=95151"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/95151\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/95152"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=95151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=95151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=95151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}